Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Maze Therapeutics (MAZE) Other Gross PP&E Adjustments (2024 - 2026)

Maze Therapeutics' Other Gross PP&E Adjustments history spans 3 years, with the latest figure at -$20.8 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 12.37% to -$20.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$20.8 million, a 12.37% increase, with the full-year FY2025 number at $3.5 million, up 259.44% from a year prior.
  • Other Gross PP&E Adjustments hit -$20.8 million in Q1 2026 for Maze Therapeutics, down from $3.5 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for MAZE hit a ceiling of $3.5 million in Q4 2025 and a floor of -$23.7 million in Q1 2025.
  • Historically, Other Gross PP&E Adjustments has averaged -$14.6 million across 3 years, with a median of -$21.4 million in 2025.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 259.44% in 2025 and later increased 12.37% in 2026.
  • Tracing MAZE's Other Gross PP&E Adjustments over 3 years: stood at -$2.2 million in 2024, then surged by 259.44% to $3.5 million in 2025, then tumbled by 697.13% to -$20.8 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for MAZE at -$20.8 million in Q1 2026, $3.5 million in Q4 2025, and -$22.0 million in Q3 2025.